BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 31236701)

  • 1. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
    Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
    Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
    Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic efficacy of the Liver Imaging-Reporting and Data System (LI-RADS) with CT imaging in categorising small nodules (10-20 mm) detected in the cirrhotic liver at screening ultrasound.
    Abd Alkhalik Basha M; Abd El Aziz El Sammak D; El Sammak AA
    Clin Radiol; 2017 Oct; 72(10):901.e1-901.e11. PubMed ID: 28673446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of small (≤ 3 cm) hepatocellular carcinomas from benign nodules in cirrhotic liver: the added additive value of MRI-based radiomics analysis to LI-RADS version 2018 algorithm.
    Zhong X; Guan T; Tang D; Li J; Lu B; Cui S; Tang H
    BMC Gastroenterol; 2021 Apr; 21(1):155. PubMed ID: 33827440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
    Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J
    Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B
    Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma.
    Nakayama A; Imamura H; Matsuyama Y; Kitamura H; Miwa S; Kobayashi A; Miyagawa S; Kawasaki S
    Ann Surg; 2001 Jul; 234(1):56-62. PubMed ID: 11420483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fat-containing hepatocellular carcinoma in patients with cirrhosis: proposal of a diagnostic modification regarding enhancement characteristics.
    Delagnes A; Roux M; Vilgrain V; Guiu B; Laurent V; Sutter O; Bricault I; Trillaud H; Aubé C; Paisant A
    Eur Radiol; 2024 Apr; 34(4):2283-2293. PubMed ID: 37816923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The magnetic resonance of small hepatocarcinoma. A comparison with echography, computed tomography, digital angiography and computed tomography with lipiodol].
    De Santis M; Cristani A; Cioni G; Casolo A; Canossi G; Ventura E; Romagnoli R
    Radiol Med; 1992 Nov; 84(5):587-95. PubMed ID: 1335589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
    Schellhaas B; Hammon M; Strobel D; Pfeifer L; Kielisch C; Goertz RS; Cavallaro A; Janka R; Neurath MF; Uder M; Seuss H
    Eur Radiol; 2018 Oct; 28(10):4254-4264. PubMed ID: 29675659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?
    Kim SS; Hwang JA; Shin HC; Choi SY; Kang TW; Jou SS; Lee WH; Park S; Heo NH
    Eur Radiol; 2019 Jan; 29(1):186-194. PubMed ID: 30073499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT portography and post-lipiodol CT in the preinterventional work-up of primary and secondary liver tumors. A single center experience.
    Malagari K; Koskinas J; Brountzos E; Thanos L; Papathanasiou M; Dailiana T; Hadziyannis S; Kelekis D
    Hepatogastroenterology; 1999; 46(29):2901-8. PubMed ID: 10576370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules ≤ 2 cm in cirrhotic patients.
    Darnell A; Rimola J; Belmonte E; Ripoll E; Garcia-Criado Á; Caparroz C; Díaz-González Á; Vilana R; Reig M; Ayuso C; Bruix J; Forner A
    Eur Radiol; 2021 Jul; 31(7):4794-4803. PubMed ID: 33409789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
    Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
    Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
    Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
    World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of contrast-enhanced intraoperative ultrasound for cirrhotic patients with hepatocellular carcinoma: a report of 20 cases.
    Lu Q; Luo Y; Yuan CX; Zeng Y; Wu H; Lei Z; Zhong Y; Fan YT; Wang HH; Luo Y
    World J Gastroenterol; 2008 Jul; 14(25):4005-10. PubMed ID: 18609684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.